en

PRODUCT DETAIL

Rivaroxaban G.L. Pharma 15 mg filmom obalené tablety

Code 6461D
MA number 16/0018/21-S
Product Form: tbl flm 100x15 mg (blis.PVC/PVDC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AF Direct factor Xa inhibitors
B01AF01 Rivaroxaban
Shelf life: 36
Container: blister PVC/PVDC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 11.03.2021
Validity: 11.03.2026
SPC: SPC_Rivaroxaban G.L. Pharma 15 mg_tbl fm_03.2024.pdf  
PIL: PIL_Rivaroxaban G.L. Pharma 15 mg a 20 mg_tbl flm_03.2024.pdf  
Safety feature Yes
Data update: 21.11.2023
eu-flag.png sk-flag.png